Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Portopulmonary hypertension.

Michael Halank1, Ralf Ewert, Hans-Juergen Seyfarth

  • 1Carl Gustav Carus University Dresden, Internal Medicine I, Fetscherstr. 74, 01307 Dresden, Germany.

Journal of Gastroenterology
|October 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of cognitive performance by demographics, sleep, and brain morphometry: machine learning findings from ENIGMA-Sleep Working Group.

Research square·2026
Same author

Functional characterization of <b><i>KCNA5</i></b> gene variants linked to pulmonary arterial hypertension.

The European respiratory journal·2026
Same author

Ventilatory efficiency: Physiological modelling and mechanistic validation.

The Journal of physiology·2026
Same author

Parapharyngeal Fat Pads as an Obesity-Related Parameter for Apnea-Hypopnea Index Severity.

Journal of sleep research·2026
Same author

Breathing bad: increased risk for obstructive sleep apnea in current and former smokers.

Scientific reports·2026
Same author

Sex differences in obstructive sleep apnea: a population-based study from northeastern Germany.

Sleep & breathing = Schlaf & Atmung·2026
Same journal

Immediate prediction of post-ERCP pancreatitis: a novel approach using serum trypsin.

Journal of gastroenterology·2026
Same journal

Enhanced COMP expression induced by Helicobacter pylori drives gastric cancer progression by NOTCH2/SMAD3 pathway.

Journal of gastroenterology·2026
Same journal

Comment on "Dependence-related screening positivity among regular stimulant-laxative users with chronic constipation: a multicenter prospective observational study".

Journal of gastroenterology·2026
Same journal

Comment on "Dependence-related screening positivity among regular stimulant-laxative users with chronic constipation: a multicenter prospective observational study".

Journal of gastroenterology·2026
Same journal

METTL3/FTO drives ferroptosis in colorectal cancer by targeting m<sup>6</sup>A modification of MUC1 mRNA and YTHDF2-dependent SLC7A11/GSH pathway.

Journal of gastroenterology·2026
Same journal

Risk of lymph-node metastasis in early onset T1 colorectal cancer: a systematic review and meta-analysis.

Journal of gastroenterology·2026
See all related articles

Portopulmonary hypertension (PPHT) is a serious condition requiring focused treatment. Current therapies include prostacyclin, bosentan, and sildenafil, but more research is needed.

Area of Science:

  • Cardiology
  • Hepatology
  • Pulmonology

Background:

  • Portopulmonary hypertension (PPHT) is defined as precapillary pulmonary hypertension with hepatic or portal hypertension.
  • Pathogenesis involves pulmonary vascular remodeling, vasoconstriction, volume overload, hyperdynamic circulation, and vasoactive mediators.
  • PPHT significantly impacts survival and complicates liver transplantation.

Purpose of the Study:

  • To review the current understanding of portopulmonary hypertension (PPHT) pathogenesis.
  • To discuss the impact of PPHT on patient survival and liver transplantation outcomes.
  • To evaluate current and emerging medical treatments for PPHT.

Main Methods:

  • Literature review of portopulmonary hypertension (PPHT).
  • Analysis of existing data on PPHT pathogenesis and treatment.

Related Experiment Videos

  • Evaluation of therapeutic options including prostacyclin, endothelin-receptor antagonists, and phosphodiesterase-5 inhibitors.

    • Main Results:

    • PPHT shares histological features with other pulmonary arterial hypertension forms.
    • Continuous intravenous prostacyclin is considered the treatment of choice for severe PPHT.
    • Bosentan and sildenafil show emerging efficacy in selected PPHT patients, with potential for combination therapy.

    Conclusions:

    • PPHT requires focused treatment due to its substantial impact on survival.
    • Beta-blockers may be harmful in moderate to severe PPHT.
    • Randomized, double-blind, controlled clinical trials are urgently needed to establish optimal PPHT treatment.